CS
ELV icon

Cannell & Spears’s Elevance Health ELV Stock Holding History

Cannell & Spears’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.1M Buy
26,050
+2,480
+11% +$920K 0.18% 102
2026
Q1 		$6.9M Buy
23,570
+8,897
+61% +$2.92M 0.14% 113
2025
Q4 		$5.14M Sell
14,673
-594
-4% -$201K 0.1% 133
2025
Q3 		$4.93M Sell
15,267
-11,137
-42% -$3.46M 0.09% 145
2025
Q2 		$10.3M Buy
26,404
+176
+0.7% +$70.8K 0.21% 98
2025
Q1 		$11.4M Sell
26,228
-2,194
-8% -$881K 0.25% 91
2024
Q4 		$10.5M Sell
28,422
-37,810
-57% -$15.8M 0.22% 98
2024
Q3 		$34.4M Sell
66,232
-571
-0.9% -$305K 0.68% 51
2024
Q2 		$36.2M Buy
66,803
+121
+0.2% +$64K 0.75% 43
2024
Q1 		$34.6M Buy
66,682
+1,995
+3% +$992K 0.71% 45
2023
Q4 		$30.5M Buy
64,687
+182
+0.3% +$84.2K 2.43% 15
2023
Q3 		$28.1M Buy
64,505
+49
+0.1% +$22.2K 2.41% 16
2023
Q2 		$28.6M Buy
64,456
+59,858
+1,302% +$27.6M 2.34% 15
2023
Q1 		$2.11M Buy
+4,598
New +$2.19M 0.19% 60

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Cannell & Spears's ELV Position: Q2 2026 in Review

Cannell & Spears increased its Elevance Health (ELV) stake by 11% in Q2 2026, buying an estimated $920K and bringing the position to 26,050 shares worth $10.1M. The position accounts for 0.18% of the portfolio, ranked #102.

Cannell & Spears first reported a position in ELV in Q1 2023 and has held it in 14 quarters since. The position peaked at $36.2M in Q2 2024. 1,606 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Cannell & Spears held 26,050 shares of Elevance Health worth $10.1M as of Q2 2026.
  • Cannell & Spears bought 2,480 Elevance Health shares in Q2 2026, an estimated $920K.
  • Elevance Health made up 0.18% of Cannell & Spears's portfolio in Q2 2026, its #102 holding.
  • Cannell & Spears first reported a position in Elevance Health in Q1 2023 and has held it in 14 quarters since.
  • Cannell & Spears's Elevance Health position peaked at $36.2M in Q2 2024.
  • 1,606 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Cannell & Spears's 13F filing for Q2 2026, filed 11 Aug 2026.